Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hovind

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|April 21, 2004
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort studyPeter Hovind, Lise Tarnow, Peter Rossing, et al.
European Journal of Endocrinology|January 16, 2007
An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetesPeter Hovind, Steven Lamberts, Wim Hop, et al.
Diabetologia|July 28, 2014
Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up studyJakob A Østergaard, Steffen Thiel, Peter Hovind, et al.
Diabetes|August 9, 2012
Urinary proteomics for early diagnosis in diabetic nephropathyPetra Zürbig, George Jerums, Peter Hovind, et al.
Obesity (Silver Spring, Md.)|June 14, 2023
Age- and sex-specific changes in visceral fat mass throughout the life-spanRikke Bannebjerg Baarts, Mads Radmer Jensen, Ole Michael Hansen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2011
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trialLian Engelen, Frederik Persson, Isabel Ferreira, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 3, 2023
<sup>82</sup>Rb and [<sup>15</sup>O]H<sub>2</sub>O myocardial perfusion PET imaging: a prospective head to head comparisonMartin Krakauer, Afefah Ismail, Ulrik Talleruphuus, et al.
Journal of Hypertension|September 2, 2017
Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?Jon J Rasmussen, Morten Schou, Per L Madsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2020
The Renal Extraction and the Natriuretic Action of GLP-1 in Humans Depend on Interaction With the GLP-1 ReceptorAli Asmar, Per K Cramon, Meena Asmar, et al.
Diabetes Care|July 27, 2005
Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathySofia B Ahmed, Peter Hovind, Hans-Henrik Parving, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|April 21, 2004
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort studyPeter Hovind, Lise Tarnow, Peter Rossing, et al.
European Journal of Endocrinology|January 16, 2007
An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetesPeter Hovind, Steven Lamberts, Wim Hop, et al.
Diabetologia|July 28, 2014
Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up studyJakob A Østergaard, Steffen Thiel, Peter Hovind, et al.
Diabetes|August 9, 2012
Urinary proteomics for early diagnosis in diabetic nephropathyPetra Zürbig, George Jerums, Peter Hovind, et al.
Obesity (Silver Spring, Md.)|June 14, 2023
Age- and sex-specific changes in visceral fat mass throughout the life-spanRikke Bannebjerg Baarts, Mads Radmer Jensen, Ole Michael Hansen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2011
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trialLian Engelen, Frederik Persson, Isabel Ferreira, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 3, 2023
<sup>82</sup>Rb and [<sup>15</sup>O]H<sub>2</sub>O myocardial perfusion PET imaging: a prospective head to head comparisonMartin Krakauer, Afefah Ismail, Ulrik Talleruphuus, et al.
Journal of Hypertension|September 2, 2017
Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?Jon J Rasmussen, Morten Schou, Per L Madsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2020
The Renal Extraction and the Natriuretic Action of GLP-1 in Humans Depend on Interaction With the GLP-1 ReceptorAli Asmar, Per K Cramon, Meena Asmar, et al.
Diabetes Care|July 27, 2005
Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathySofia B Ahmed, Peter Hovind, Hans-Henrik Parving, et al.
Pageof 6